DNA Sequencing Market Overview and Introduction                              

DNA sequencing can be defined as the process of determining the sequence of nucleotides in a piece of the DNA. The process involves technologies which determine the order of four bases, viz., adenine, thymine, guanine, and cytosine. The advent of DNA sequencing techniques have significantly accelerated medical & biological research & discovery.  This process is widely used for the purpose of determining sequence of genes, chromosomes or even an entire genome. DNA sequencing also acts as an effective tool for sequencing RNAs as well as proteins. Currently, DNA sequencing finds a broad range of application across diverse areas of biology such as anthropology, medicine, biotechnology, molecular biology, metagenomics, virology, and forensics among others.

The global DNA sequencing has been particularly driven by the advent of novel technologies, which have significantly reduced time associated with sequencing process. Moreover, growing application of sequencing processes for several clinical applications such as reproductive health, cancer, genetic disorders and other complex disorders, is anticipated to further contribute to the growth of the market in the coming years. Furthermore, development of low cost, high-throughput parallel sequencing technology, has generated rich data sets, that can be used to study & analyze several vital aspects, such as genetic disease risk, population diversity, treatment response, and human evolution. Although, introduction of latest technologies have significantly lowered prices associated with sequencing, but such costs need to decline further to enable its increased adoption. Similarly, ethical & social issues regarding security & privacy of genetics data generated of an individual, still remains a major source of concern.

The global DNA sequencing market is majorly classified into the following segments, viz., by product, application, technology, end user and region.

DNA Sequencing Market by Product

The segment of products can be broken down into the following categories, instruments, consumables and services. The instruments segment is projected to account for the highest CAGR during the forecast period owing to continuous introduction of advanced sequencing instruments.

DNA Sequencing Market by Application

On the basis of application, the DNA sequencing market is bifurcated into, diagnostics, reproductive health, forensics, biomarkers & cancer and personalized medicine and other applications. Rising incidences & prevalence of cancer is anticipated to significantly contribute to the growth of the global DNA sequencing market. This segment is anticipated to account for the highest CAGR in the coming years.

DNA Sequencing Market by Technology

On the basis of technology, the DNA sequencing market is bifurcated into, sequencing by synthesis, sequencing by ligation, single-molecule real-time sequencing, nanopore sequencing, ion semiconductor sequencing, pyrosequencing, and chain termination sequencing.

DNA Sequencing Market by End User

On the basis of end user, the DNA sequencing market is bifurcated into, academic & government research institutes, biotechnology & pharmaceutical companies, hospitals & clinics and other end users.

DNA Sequencing Market by Region

The global DNA sequencing market can be segmented into North America, Asia Pacific, Europe and Rest of World (ROW). North America dominated the global DNA sequencing market in 2019, owing to factors such as availability of advanced research facilities, and favorable government regulations supporting research studies among others. However, Asia Pacific is anticipated to clock the highest CAGR during the forecast period. The considerable growth of the DNA sequencing market in this region can be attributed to increasing government focus on research, improving healthcare infrastructure, and rising awareness regarding advanced DNA sequencing techniques.

DNA Sequencing Market Prominent Players

The prominent players operating in the global DNA sequencing market are Abbott Laboratories, Agilent Technologies, Inc., Danaher (Beckman Coulter), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR, Inc., Pacific Biosciences of California, Inc., Oxford Nanopore Technologies, Bio-Rad Laboratories, Inc., and Thermo Fisher Scientific Inc. among others